ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 88 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280 | +294.4% | 220,858 | 0.0% | 0.01% | +500.0% |
Q2 2023 | $71 | -24.5% | 220,858 | +0.8% | 0.00% | -50.0% |
Q1 2023 | $94 | -17.5% | 219,146 | +1.6% | 0.00% | -33.3% |
Q4 2022 | $114 | -99.9% | 215,722 | +1.6% | 0.00% | -25.0% |
Q3 2022 | $155,000 | -61.1% | 212,298 | -39.2% | 0.00% | -63.6% |
Q2 2022 | $398,000 | -44.6% | 349,336 | -0.5% | 0.01% | -35.3% |
Q1 2022 | $719,000 | -39.1% | 351,154 | -14.4% | 0.02% | -32.0% |
Q4 2021 | $1,180,000 | -26.8% | 410,062 | +7.7% | 0.02% | -24.2% |
Q3 2021 | $1,613,000 | -18.1% | 380,698 | +2.2% | 0.03% | -8.3% |
Q2 2021 | $1,969,000 | +18.8% | 372,384 | +4.3% | 0.04% | +16.1% |
Q1 2021 | $1,658,000 | +290.1% | 356,876 | +176.1% | 0.03% | +210.0% |
Q4 2020 | $425,000 | +98.6% | 129,252 | +98.8% | 0.01% | +25.0% |
Q3 2020 | $214,000 | -32.9% | 65,002 | -31.5% | 0.01% | -50.0% |
Q2 2020 | $319,000 | -5.1% | 94,962 | +8.0% | 0.02% | -30.4% |
Q1 2020 | $336,000 | +168.8% | 87,942 | +250.0% | 0.02% | +187.5% |
Q4 2019 | $125,000 | -11.3% | 25,128 | +34.2% | 0.01% | -33.3% |
Q3 2019 | $141,000 | – | 18,726 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
Leap Investments LP | 46,084 | $348,000 | 0.17% |
Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |